Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease (Q34634606)

3 August 2017

Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease (English)

1 reference

3 August 2017

1 reference

1 reference

Mohd Moshahid Khan

1

1 reference

3 August 2017

Syed Shadab Raza

2

1 reference

3 August 2017

Hayate Javed

3

1 reference

3 August 2017

Ajmal Ahmad

4

1 reference

3 August 2017

Andleeb Khan

5

1 reference

3 August 2017

Farah Islam

6

1 reference

3 August 2017

Mohammed M Safhi

7

1 reference

3 August 2017

Fakhrul Islam

8

1 reference

3 August 2017

23 December 2011

1 reference

3 August 2017

Neurotoxicity Research

1 reference

3 August 2017

22

1 reference

3 August 2017

1

1 reference

3 August 2017

1-15

1 reference

https://scigraph.springernature.com/pub.10.1007/s12640-011-9295-2

3 August 2017

0 references

cites work

Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

The 6-hydroxydopamine model: news from the past

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Metabolism and functions of glutathione in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Selenium-induced alteration of lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Rutin protects the neural damage induced by transient focal ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines: protective effect of rutin against toxicant-induced hippocampal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

A fluorometric assay for the measurement of nitrite in biological samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Protective effect of buckwheat polyphenols against long-lasting impairment of spatial memory associated with hippocampal neuronal damage in rats subjected to repeated cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Free radicals, antioxidant enzymes, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-011-9295-2

Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type

21 January 2018

1 reference

12 December 2020

Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes

1 reference

12 December 2020

Oxidative stress and Parkinson's disease

1 reference

12 December 2020

Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions

1 reference

12 December 2020

Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia

1 reference

12 December 2020

Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation

1 reference

12 December 2020

Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer.

1 reference

12 December 2020

Biology of disease: free radicals and tissue injury

1 reference

12 December 2020

Glutathione metabolism and its selective modification

1 reference

12 December 2020

Determination of carbonyl content in oxidatively modified proteins

1 reference

12 December 2020

Purification and characterization of the flavoenzyme glutathione reductase from rat liver

1 reference

12 December 2020

Neurobehavioral, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Neuroinflammatory processes in Parkinson's disease

1 reference

12 December 2020

The role of glial reaction and inflammation in Parkinson's disease.

1 reference

12 December 2020

10.1007/S12640-011-9295-2

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference